Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cann Group ( (AU:CAN) ) has provided an update.
Cann Group Limited reported a sharp turnaround in its half-year results to 31 December 2025, posting a profit after tax of $26.4 million compared with a loss of $10.7 million a year earlier. This swing to profitability came despite a 30 per cent decline in revenues from ordinary activities to $4.52 million, with basic and diluted earnings per share improving to 3.15 cents from a loss of 2.23 cents.
The company did not declare or pay any dividends for the period, and net tangible assets per share improved to 2.30 cents from negative territory a year earlier. The interim financial statements were reviewed with an unmodified conclusion, although the auditor flagged a material uncertainty related to the group’s ability to continue as a going concern, highlighting ongoing financial risks for shareholders despite the headline profit.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is an Australian company operating in the medicinal cannabis sector. The group focuses on the cultivation and production of cannabis-based products for medical and related markets, aiming to supply both domestic and potentially international customers as regulatory frameworks evolve.
Average Trading Volume: 11,539,069
Technical Sentiment Signal: Sell
Current Market Cap: A$9.53M
For an in-depth examination of CAN stock, go to TipRanks’ Overview page.